Literature DB >> 29416027

Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury.

Agostino Cilibrizzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29416027      PMCID： PMC5803208          DOI： 10.1038/s41467-017-02654-2

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


× No keyword cloud information.
  15 in total

1.  β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.

Authors:  Richard Carr; Justin Schilling; Jianliang Song; Rhonda L Carter; Yang Du; Sungsoo M Yoo; Christopher J Traynham; Walter J Koch; Joseph Y Cheung; Douglas G Tilley; Jeffrey L Benovic
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

Review 2.  Molecular biology for formyl peptide receptors in human diseases.

Authors:  Yongsheng Li; Duyun Ye
Journal:  J Mol Med (Berl)       Date:  2013-02-13       Impact factor: 4.599

3.  Structure-based discovery of opioid analgesics with reduced side effects.

Authors:  Aashish Manglik; Henry Lin; Dipendra K Aryal; John D McCorvy; Daniela Dengler; Gregory Corder; Anat Levit; Ralf C Kling; Viachaslau Bernat; Harald Hübner; Xi-Ping Huang; Maria F Sassano; Patrick M Giguère; Stefan Löber; Grégory Scherrer; Brian K Kobilka; Peter Gmeiner; Bryan L Roth; Brian K Shoichet
Journal:  Nature       Date:  2016-08-17       Impact factor: 49.962

4.  Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

Authors:  Liliya N Kirpotina; Andrei I Khlebnikov; Igor A Schepetkin; Richard D Ye; Marie-Josèphe Rabiet; Mark A Jutila; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

5.  2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.

Authors:  Claudia Vergelli; Igor A Schepetkin; Giovanna Ciciani; Agostino Cilibrizzi; Letizia Crocetti; Maria Paola Giovannoni; Gabriella Guerrini; Antonella Iacovone; Liliya N Kirpotina; Andrei I Khlebnikov; Richard D Ye; Mark T Quinn
Journal:  Bioorg Med Chem       Date:  2016-04-08       Impact factor: 3.641

6.  Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

Authors:  Maria Paola Giovannoni; Igor A Schepetkin; Agostino Cilibrizzi; Letizia Crocetti; Andrei I Khlebnikov; Claes Dahlgren; Alessia Graziano; Vittorio Dal Piaz; Liliya N Kirpotina; Serena Zerbinati; Claudia Vergelli; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2013-04-08       Impact factor: 6.514

7.  6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

Authors:  Agostino Cilibrizzi; Mark T Quinn; Liliya N Kirpotina; Igor A Schepetkin; Jeff Holderness; Richard D Ye; Marie-Josephe Rabiet; Claudio Biancalani; Nicoletta Cesari; Alessia Graziano; Claudia Vergelli; Stefano Pieretti; Vittorio Dal Piaz; Maria Paola Giovannoni
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

8.  Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor.

Authors:  Anthony Yiu-Ho Woo; Krzysztof Jozwiak; Lawrence Toll; Mary J Tanga; Joseph A Kozocas; Lucita Jimenez; Ying Huang; Ying Song; Anita Plazinska; Karolina Pajak; Rajib K Paul; Michel Bernier; Irving W Wainer; Rui-Ping Xiao
Journal:  J Biol Chem       Date:  2014-05-15       Impact factor: 5.157

9.  Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.

Authors:  Roland Seifert; Stefan Dove
Journal:  Mol Pharmacol       Date:  2008-11-10       Impact factor: 4.436

10.  Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice.

Authors:  Cheng Xue Qin; Lauren T May; Renming Li; Nga Cao; Sarah Rosli; Minh Deo; Amy E Alexander; Duncan Horlock; Jane E Bourke; Yuan H Yang; Alastair G Stewart; David M Kaye; Xiao-Jun Du; Patrick M Sexton; Arthur Christopoulos; Xiao-Ming Gao; Rebecca H Ritchie
Journal:  Nat Commun       Date:  2017-02-07       Impact factor: 14.919
View more
  1 in total

1.  Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening.

Authors:  Giuseppe Floresta; Letizia Crocetti; Maria Paola Giovannoni; Pierfrancesco Biagini; Agostino Cilibrizzi
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.